Clinical resistance to velpatasvir (GS-5816), a novel pan-genotypic inhibitor of the hepatitis C virus NS5A protein

Eric J. Lawitz, Hadas Dvory-Sobol, Brian P. Doehle, Angela S. Worth, John McNally, Diana M. Brainard, John O. Link, Michael D. Miller, Hongmei Mo

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint Dive into the research topics of 'Clinical resistance to velpatasvir (GS-5816), a novel pan-genotypic inhibitor of the hepatitis C virus NS5A protein'. Together they form a unique fingerprint.

Medicine & Life Sciences